JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.92B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.2B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
iShares MBS ETF
MBB
|
+$780M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.34B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.3B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.6B |
| 4 |
Texas Instruments
TXN
|
+$1.53B |
| 5 |
Tesla
TSLA
|
+$1.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 10.45% |
| 3 | Consumer Discretionary | 10.06% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXPR
4676
DELISTED
Express, Inc.
EXPR
| $177K | ﹤0.01% |
9,731
-26,589
| -73% | -$502K |
|
4677
CALL
Dell
DELL
$320B
| $176K | ﹤0.01% |
4,735
-59,585
| -93% | -$2.08M |
|
4678
Annexon
ANNX
$862M
| $175K | ﹤0.01% |
7,013
+1,517
| +28% | +$39K |
|
|
PRVL
4679
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $175K | ﹤0.01% |
7,560
-39,047
| -84% | -$495K |
|
4680
Schwab US Large- Cap ETF
SCHX
$75B
| $174K | ﹤0.01% |
11,454
+102
| +0.9% | +$1.46K |
|
4681
Sumitomo Mitsui Financial
SMFG
$167B
| $173K | ﹤0.01% |
28,105
+15
| +0.1% | +$88 |
|
4682
Nurix Therapeutics
NRIX
$2.82B
| $172K | ﹤0.01% |
5,231
+1,091
| +26% | +$36.2K |
|
4683
AudioCodes
AUDC
$253M
| $171K | ﹤0.01% |
6,172
-1,971
| -24% | -$57.8K |
|
4684
Invesco KBW High Dividend Yield Financial ETF
KBWD
$433M
| $171K | ﹤0.01% |
10,333
+7,824
| +312% | +$118K |
|
4685
Mercer International
MERC
$33.8M
| $171K | ﹤0.01% |
16,726
-2,342
| -12% | -$18.7K |
|
4686
iShares Global 100 ETF
IOO
$9.46B
| $170K | ﹤0.01% |
2,700
-859
| -24% | -$51.1K |
|
|
ITOS
4687
DELISTED
iTeos Therapeutics
ITOS
| $170K | ﹤0.01% |
5,036
+1,052
| +26% | +$27.9K |
|
4688
Mastech Digital
MHH
$95.3M
| $170K | ﹤0.01% |
10,686
+8,369
| +361% | +$151K |
|
4689
Talphera
TLPH
$62.8M
| $169K | ﹤0.01% |
6,809
+5,210
| +326% | +$159K |
|
|
ORAN
4690
DELISTED
Orange
ORAN
| $168K | ﹤0.01% |
14,170
+558
| +4% | +$6.53K |
|
4691
Viking Therapeutics
VKTX
$3.84B
| $167K | ﹤0.01% |
29,800
+5,358
| +22% | +$32.5K |
|
4692
LENSAR
LNSR
$102M
| $166K | ﹤0.01% |
+22,796
| New | +$196K |
|
|
LNW
4693
CALL
DELISTED
Light & Wonder
LNW
| $166K | ﹤0.01% |
4,000
| – | – |
|
4694
Savara
SVRA
$1.08B
| $166K | ﹤0.01% |
143,729
+125,737
| +699% | +$152K |
|
4695
Cue Biopharma
CUE
$131M
| $165K | ﹤0.01% |
438
+80
| +22% | +$32K |
|
4696
CALL
Analog Devices
ADI
$186B
| $163K | ﹤0.01% |
+1,100
| New | +$146K |
|
4697
Altisource Portfolio Solutions
ASPS
$65.6M
| $163K | ﹤0.01% |
1,586
+1,151
| +265% | +$119K |
|
4698
ProShares Ultra S&P500
SSO
$8.51B
| $163K | ﹤0.01% |
7,128
+5,180
| +266% | +$106K |
|
4699
Biodesix
BDSX
$251M
| $162K | ﹤0.01% |
+401
| New | +$125K |
|
4700
CapForce IBD 50 ETF
FFTY
$80.5M
| $162K | ﹤0.01% |
3,942
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2020 Portfolio in Review
As of Q4 2020, JP Morgan Chase held 6,220 positions worth $681B, up 14% from $595B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2020 filing shows 531 new, 2,858 increased, 1,755 reduced and 504 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,811,161 shares worth $223M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2020 buy was Apartment Income REIT Corp.: 5,811,161 shares worth $223M.
- JP Morgan Chase added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $3.92B increase.
- JP Morgan Chase's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.34B.
- JP Morgan Chase fully exited Bank of America Series L in Q4 2020, selling an estimated $117M.
- JP Morgan Chase's ten largest holdings make up 16% of its $681B portfolio in Q4 2020.
- JP Morgan Chase opened 531 new positions and closed 504 in Q4 2020.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $681B.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.